SCHEMBL3847508

SCHEMBL3847508

Cc1nc(-c2cnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(F)cc4)cn23)no1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.46
PIK3CB P42338 1/20 0.46
MTOR P42345 1/20 0.46
CDK19 Q9BWU1 1/20 0.46
TGFBR1 P36897 7/20 0.37
ADORA2A P29274 1/20 0.34
ADORA2B P29275 1/20 0.34
ADORA1 P30542 1/20 0.34
FLT3 P36888 3/20 0.34
MAPK14 Q16539 2/20 0.34
JAK2 O60674 2/20 0.34
JAK3 P52333 2/20 0.34
JAK1 P23458 1/20 0.34
ALOX5 P09917 1/20 0.33
CHEK1 O14757 1/20 0.32
NTRK1 P04629 1/20 0.32
PIM1 P11309 1/20 0.32
CDK2 P24941 1/20 0.32
CSNK2A1 P68400 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3848861 0.90 ALDH1A1 (0.36) PIK3CAPIK3CBMTORCDK19TGFBR1
SCHEMBL3847074 0.87 LMNA (0.38) PIK3CAPIK3CBMTORCDK19TGFBR1
SCHEMBL3845245 0.85 FLT3 (0.39) TGFBR1FLT3MAPK14JAK2JAK3
SCHEMBL3847509 0.85 PIK3CA (0.40) PIK3CAPIK3CBMTORCDK19TGFBR1
SCHEMBL3848981 0.85 PIK3CA (0.33) PIK3CAPIK3CBMTORCDK19TGFBR1
SCHEMBL13874585 0.84 PIK3CA (0.49) PIK3CAPIK3CBMTORCDK19FLT3
SCHEMBL3846502 0.81 PIK3CA (0.40) PIK3CAPIK3CBMTORCDK19TGFBR1
SCHEMBL3846734 0.81 MKNK1 (0.44) TGFBR1FLT3PIM1
SCHEMBL3850397 0.81 FLT3 (0.43) TGFBR1ADORA2AADORA2BADORA1FLT3
SCHEMBL3856378 0.81 TGFBR1 (0.36) PIK3CAPIK3CBMTORCDK19TGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed